LRb-STAT3 Signaling Is Required for the Neuroendocrine Regulation of Energy Expenditure by Leptin

Sarah H. Bates1,2 Trevor A. Dundon,1 Matthew Seifert,1 Michael Carlson,1 Eleftheria Maratos-Flier,1 and Martin G. Myers, Jr.1,2

Secretion of leptin from adipose tissue communicates body energy status to the neuroendocrine system by activating the long form of the leptin receptor (LRb). Lack of leptin or LRb (as in db/db mice) results in obesity that stems from the combined effects of hyperphagia and decreased energy expenditure. We have previously generated mice in which LRb is replaced with a mutant LRb (LRbS1138) that specically disrupts LRb3 STAT3 (signal transducer and activator of transcription-3) signaling; mice homozygous for this mutant (s/s) display increased feeding and are obese. We have now examined energy expenditure in s/s and db/db mice. Consistent with the increased lean body mass of s/s animals, locomotor activity and acute cold tolerance (partly a measure of shivering thermogenesis) in s/s mice were modestly but signicantly improved compared with db/db mice, although they were decreased compared with wild-type mice. Total and resting metabolic rates were similarly depressed in s/s and db/db mice, however. Indeed, s/s and db/db mice display similar reductions in thyroid function and brown adipose tissue expression of uncoupling protein-1, which is regulated by sympathetic nervous system (SNS) tone. Thus, the LRb3 STAT3 signal is central to both the control of energy expenditure by leptin and the neuroendocrine regulation of the SNS and the thyroid axis. Diabetes 53:30673073, 2004

he incidence of type 2 diabetes in industrialized nations has increased dramatically over the past two decades and continues to increase; much of this increase is attributable to the skyrocketing incidence of obesity in these populations (1,2). The recent

From the 1Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts; and the 2Department of Internal Medicine, Metabolism, Endocrinology and Diabetes, University of Michigan Medical School, Ann Arbor, Michigan. Address correspondence and reprint requests to Martin G. Myers, Jr., MD, PhD, Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, 1150 W. Medical Center Dr., 4301 MSRB 3, Box 0638, Ann Arbor, MI 48109-0638. E-mail: mgmyers@umich.edu. Received for publication 27 May 2004 and accepted in revised form 23 August 2004. T.A.D. is currently afliated with the Department of Cell and Developmental Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. BAT, brown adipose tissue; DEXA, dual-energy X-ray absorptiometry; NPY, neuropeptide Y; SNS, sympathetic nervous system; STAT3, signal transducer and activator of transcription-3; TRH, thyrotropin-releasing hormone; UCP1, uncoupling protein 1. 2004 by the American Diabetes Association. DIABETES, VOL. 53, DECEMBER 2004

identication of numerous regulators of appetite and energy expenditure has facilitated the molecular study of appetite and energy expenditure and potential mechanisms underlying obesity (3 6). One such regulator is leptin, the product of the obese (ob) gene (4,7). Leptin is a hormone that is secreted by adipose tissue to signal the status of body energy stores to the central nervous system (8). As a signal of energy sufciency, adequate leptin levels suppress feeding and permit energy-costly neuroendocrine functions (4,9 12). Conversely, negative energy balance decreases leptin levels, increasing the drive to feed and triggering neuroendocrine responses that limit energy expenditure (9). In addition to limiting energy-costly nonsurvival functions such as growth and reproduction, low leptin levels decrease minute-to-minute energy utilization by decreasing the metabolic rate of various tissues. Thus, the absence of leptin or the long signaling form of the leptin receptor (LRb) in ob/ob and db/db mice, respectively, results in a phenotype of obesity secondary to hyperphagia and decreased metabolic rate (due at least in part to hypothyroidism and decreased sympathetic nervous system [SNS] tone) plus altered nutrient partitioning, decreased growth, and infertility (4,5). Total momentary energy expenditure equals the sum of energy expended in physical work (e.g., volitional movement and shivering) plus resting metabolic rate. The resting metabolic rate is the pace at which energy is utilized by tissues (most precisely measured at rest under thermoneutral conditions and in the postabsorptive state) and approximates the product of tissue metabolic rate times the mass of metabolically active tissues. Important neuroendocrine determinants of tissue metabolic rate include thyroid hormone and SNS tone, which are decreased in leptin-decient states (13,14). Leptin regulates thyrotropin-releasing hormone (TRH) production in the parvocellular paraventricular nuclei to participate in the activation of the hypothalamic-pituitary-thyroid axis (9), apparently by a combination of direct and indirect mechanisms (1517). LRb-mediated signals also participate in the activation of the SNS by leptin; one well-established mechanism by which energy expenditure is regulated by SNS tone in rodents is the expression of uncoupling protein 1 (UCP1) in brown adipose tissue (BAT) (18 23). Food intake also acutely increases the rate of energy expenditure due to the work of breaking down food into metabolic fuels.
3067

REGULATION OF ENERGY EXPENDITURE BY LEPTIN

LRb, like other members of the cytokine receptor family, is itself devoid of enzymatic activity, but it mediates tyrosine kinase signaling by means of an associated Jak family tyrosine kinase (Jak2, in the case of LRb) that is activated during ligand binding (24 26). LRb signaling can be conceived of as originating from three major sites within the activated receptor complex: from each of two phosphorylation sites on LRb itself (Tyr985 and Tyr1138) and from phosphorylation sites and signaling motifs on the LRb-associated Jak2 molecule (26 28). Although signals mediated directly by motifs on the LRb-associated Jak2 are poorly characterized, it is well known that Tyr985 recruits the binding of the protein tyrosine phosphatase SHP-2 and the inhibitory suppressor of cytokine signaling-3, whereas Tyr1138 specically binds and activates the latent transcription factor signal transducer and activator of transcription-3 (STAT3) (28). By studying mice in which the gene for the leptin receptor (lepr) was replaced with a substitution mutant at Tyr1138 (leprs1138) by homologous targeting, we have previously shown that disruption of the LRb-STAT3 signal in homozygous (s/s) mice results in hyperphagia and obesity with preserved reproductive and growth function (29). Here we investigate the role of the LRb3 STAT3 pathway in leptin control of energy expenditure. We demonstrate that locomotor activity and acute/shivering thermogenesis are improved in s/s compared with db/db mice, consistent with the increased lean mass of these animals. In contrast, LRb3 STAT3 signaling is critical for the neuroendocrine regulation of resting metabolic rate because resting metabolic rate, BAT UCP1 expression, and thyroid function are similarly dysregulated in both s/s and db/db mice.
RESEARCH DESIGN AND METHODS
All animal experimentation was conducted in accordance with mandated standards of humane care approved by the institution animal care and use committee (Joslin Diabetes Center). All mice were housed in the Joslin Diabetes Centers accredited mouse barrier facility on a 12-h light/dark cycle. All mice had ad libitum access to standard chow (Purina autoclavable laboratory mouse breeder chow) and water. C57BL/6 (backcrossed n 6 generations) mice heterozygous for the leprs1138 mutation were bred to generate s/s and wild-type littermates for study. The db/db mice were obtained by breeding C57BL/6 db/ heterozygotes (the leprdb mutation used in this study is a splice mutation that specically abrogates the expression of LRb) (30 32) obtained from The Jackson Laboratory (Bar Harbor, ME). Body composition. The 6-week-old male ad libitumfed mice (wild type, s/s, and db/db) were briey anesthetized with Avertin (tribromoethanol:tert-amyl alcohol, 0.015 ml/g i.p.) and subjected to dual-energy X-ray absorptiometry (DEXA; Lunar PIXImus2 densitometer; GE Medical Systems, Madison, WI) for the analysis of fat and lean body mass. Locomotor activity. The 6-week-old male mice were housed individually with ad libitum access to food and evaluated for ambulatory activity using an OPTO-M3 sensor system (comprehensive lab animal monitoring system, or CLAMS; Columbus Instruments, Columbus, OH). A score of ambulatory activity was determined by consecutive photo-beam breaks occurring in adjacent beams. Beam breaks were counted every hour during a full light/dark cycle. Resting metabolic rate. Indirect calorimetry was measured in 6-week-old male mice using an open-circuit Oxymax system (CLAMS; Columbus Instruments). Mice were individually housed in plexiglass cages through which air of known O2 concentration was passed at a constant ow rate. After a 48-h acclimation period, exhaust air was sampled for 24 h in the fed state for the determination of O2 and CO2. Acute thermoregulation. The core body temperature of 8-week-old ad libitumfed male mice was measured at room temperature at 10:00 A.M. using a rodent telethermometer (Thermolyne; Fisher) equipped with a rectal probe, which was inserted 1 cm into the rectum and read after stabilizing for 5 s. Mice were then subjected to cold by maintenance in the bottom of a 2-l glass beaker submerged in ice for 75 min without food. Body temperature was assessed by 3068

removing the animals from the beaker (for 1 min) to measure rectal temperature at 30, 45, 60, and 75 min after the initiation of the study, and mice were killed at the end of the study or if the core body temperature decreased to 25C. UCP1 protein measurements. For measurement of basal UCP1, 8-week-old male ad libitumfed mice of genotypes / , s/s, and db/db (that had been housed at 25C) were killed by CO2 inhalation at 10:00 A.M. and interscapular BAT pads were removed and immediately snap-frozen. The frozen fat pads were homogenized in lysis buffer (20 mmol/l Tris, pH 7.4, containing 137 mmol/l NaCl, 2 mmol/l EDTA, 10% glycerol, 50 mmol/l -glycerophosphate, 50 mmol/l NaF, 1% Nonidet P40, 2 mmol/l phenylmethylsulphonyl uoride, and 2 mmol/l sodium orthovanadate) using a polytron homogenizer, and they were allowed to solubilize on ice for 1 h. Insoluble material was removed by centrifugation at 16,000g at 4C for 15 min. Protein concentrations of the resulting lysates were determined, and equivalent amounts of protein were subjected to SDS-PAGE and immunoblot analysis with anti-UCP1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA) with detection by 125I-labeled protein A essentially as described (28). Hormone measurements. Free T4 was determined in 8-week-old male ad libitumfed mice killed by CO2 inhalation at 10:00 A.M. Trunk blood was collected and centrifuged at 16,000g at 4C. Serum was collected and frozen at 20C. Free T4 was assessed by radioimmunoassay (radioimmunoassaycoated tube assay; ICN, Costa Mesa, CA).

RESULTS AND DISCUSSION

Disruption of the LRb-STAT3 signal in s/s mice causes dramatic hyperphagia and obesity similar to that of db/db animals (29). Although the obese phenotype of db/db mice is known to be secondary to decreased energy expenditure as well as increased feeding, the relative contributions of hyperphagia and decreased energy expenditure to the phenotype of s/s animals have not been examined. While displaying dramatically increased body weight and body fat compared with wild-type ( / ) animals, s/s mice weigh slightly less and have a slightly lower body fat percentage by DEXA compared with db/db mice, which are devoid of all LRb signals (Fig. 1A and B). The slightly increased lean body mass of db/db compared with / animals is consistent with the addition of lean (muscle, etc.) mass required to support and move the large adipose mass of the db/db animal (Fig. 1C). The increased lean body mass of s/s animals compared with both / animals and the slightly heavier db/db animals is consistent with activation of the neuroendocrine growth axis (29). The lean mass data presented include bone mineral mass, but mineral constitutes 1.5% of total lean mass and varies only 20% among the various genotypes, thus the inclusion or exclusion of bone mineral in the lean mass calculation did not alter the observed differences in lean mass among the genotypes (data not shown). The slightly decreased body weight and percent body fat of s/s compared with db/db animals could result from increased metabolic rates/less efcient energy metabolism in s/s compared with db/db animals; we thus tried to determine the role of the LRb3 STAT3 signal in the regulation of energy expenditure and its determinants in s/s and db/db animals. To quantitatively examine parameters of energy utilization in these animals, we subjected / , s/s, and db/db animals to analysis in a comprehensive lab animal monitoring system, in which activity is continuously monitored by the breaking of light beams, and the energy utilization/ metabolic rate is monitored by the consumption of oxygen (O2) and the production of carbon dioxide (CO2) in a closed cage system. Although this apparatus can also be used for the continuous monitoring of food intake, s/s and
DIABETES, VOL. 53, DECEMBER 2004

S.H. BATES AND ASSOCIATES

FIG. 1. Body weight and composition of 6-week-old male mice with leptin receptor mutations. A: Body weights of mice of the indicated genotypes. B and C: Mice of the indicated genotypes were anesthetized and subjected to body composition analysis by DEXA; percent fat mass (B) and lean body mass (C) are plotted. The hours corresponding to the dark cycle are indicated by the black bar beneath the graph in (A). Data are plotted as the means SE for n > 8 animals of each genotype. *P < 0.05 vs. / ; **P < 0.001 vs. / ; #P < 0.05 vs. db/db by Students unpaired t test.

db/db mice are too obese to enable use of the monitored feeding system in this device; we were thus unable to assess feeding in this manner. We found that beam-break activity was decreased by 60 70% in s/s and db/db compared with / mice (Fig. 2); s/s mice displayed slightly increased activity compared with db/db animals, however, suggesting that voluntary locomotor activity is less impaired in s/s compared with db/db animals. Analysis of O2 consumption and CO2 production in these animals revealed no alterations in respiratory quotient among the three genotypes (data not shown), presumably because of the continuous presence of the same chow diet in each case. O2 consumption data are often normalized per animal or per unit of body mass, but each of these methods skews comparisons among animals with different masses of metabolically active (e.g., lean tissue such as muscle and kidney) and metabolically quiet (e.g., adipose, bone) tissues; we have thus normalized O2 consumption for each animal to lean tissue mass, derived by DEXA analysis as in Fig. 1C. It should be noted, however, that normalization by total body mass or animal did not substantially alter the statistical signicance of differences among the various genotypes (data not shown). Resting (Fig. 3A) and total 24-h (Fig. 3B) O2 consumption were reduced by 30 40% in s/s and db/db animals compared with / mice, consistent with increased metabolic efciency in these animals. Neither total 24-h nor resting O2 consumption were different between s/s and db/db animals, suggesting that the LRb3 STAT3 signal is central to the regulation of metabolic rate and energy expenditure by leptin.
DIABETES, VOL. 53, DECEMBER 2004

The preceding results suggest that the components of the neuroendocrine regulation of energy expenditure should be similarly impaired in s/s and db/db animals. To determine whether this is the case, we investigated thermogenesis by measuring tolerance to acute cold exposure, the expression of BAT UCP1 protein (a mediator of nonshivering thermogenesis that is regulated by the SNS), and circulating thyroid hormone in s/s and db/db animals. Although prolonged cold exposure studies more accurately gauge nonshivering thermogenesis than acute cold exposure studies, neither s/s nor db/db mice survive prolonged exposure to cold. We thus examined tolerance to acute cold exposure: animals accustomed to a 25C environment were placed singly in the cold for 75 min in the absence of food, and core body temperature was measured periodically. In this experimental protocol, the ability to maintain core body temperature reects primarily shivering thermogenesis, with a lesser component of nonshivering thermogenesis. Differences in initial core body temperature among genotypes at the outset of the experiment were not statistically signicant. Whereas / mice showed little variation in core body temperature during this experiment, the temperature of db/db animals dropped precipitously, such that the experiment had to be terminated early for each of these animals. This result is consistent with impairment of both shivering and nonshivering thermogenesis in the db/db animals. By contrast, although the core body temperature of s/s animals decreased during the experiment, they were able to maintain body temperatures of 33C over the duration of the cold
3069

REGULATION OF ENERGY EXPENDITURE BY LEPTIN

FIG. 2. Locomotor activity of s/s and db/db mice. Averaged activity of animals was measured by monitoring consecutive beam breaks during a single 24-h light/dark cycle in the comprehensive lab animal monitoring system. A: Averaged activity plot for animals of each genotype over a 24-h cycle is plotted. B: Total beam breaks per 24 h is plotted for animals of each genotype. Data are plotted as the means SE for n > 8 animals of each genotype. *P < 0.001 vs. / ; #P < 0.001 vs. db/db by Students unpaired t test.

exposure, demonstrating improved total thermogenesis compared with db/db animals (Fig. 4). UCP1-mediated thermogenesis in BAT is a major contributor to nonshivering thermogenesis and contributes to energy expenditure by uncoupling mitochondrial respiration from ATP synthesis; the synthesis and activity of BAT UCP1 are regulated by SNS stimulation. Impaired activity of the SNS in db/db mice decreases UCP1 expression and promotes the development of obesity. We examined UCP1 expression in / , s/s, and db/db animals acclimated to a 25C environment by immunoblotting for UCP-1 protein in

BAT extracts from these animals. As previously reported, BAT UCP1 expression was reduced 16 2% in db/db animals compared with / mice. Similarly impaired UCP1 expression was observed in BAT from s/s animals (decrease of 16 2% compared with / ), suggesting that LRb3 STAT3 signaling is required for leptin-mediated BAT UCP1 expression (Fig. 5). Because 75 min of cold exposure (as in Fig. 4) is insufcient to increase BAT UCP1 from the baseline (shown in Fig. 5), differences in cold tolerance between s/s and db/db animals are not likely to result from differences in UCP1. These observations sug-

FIG. 3. Effect of leptin receptor mutations on metabolic rate. Oxygen consumption (VO2) was monitored for 6-week-old male ad libitumfed mice of the indicated genotype during a single 24-h light/dark cycle in the comprehensive lab animal monitoring system. A: Total oxygen consumption over 24 h is shown. B: Resting oxygen consumption was derived by measuring VO2 for 1 h during which the animal in question performed <10 beam breaks. Data are normalized to lean body mass and plotted as the mean SE for n > 8 animals of each genotype. *P < 0.001 vs. / by Students unpaired t test. 3070 DIABETES, VOL. 53, DECEMBER 2004

S.H. BATES AND ASSOCIATES

FIG. 4. Dysregulation of acute thermogenesis in mice with leptin receptor mutations. Acute thermoregulation was assessed in 8-weekold male mice. Food was removed at time 0, core body temperature (Temp.) was measured, and animals were placed in a cold vessel. Then, core body temperature was assessed at the indicated times for 75 min or until decreased body temperature dictated the end of the experiment. Temperature data for n > 8 animals of each genotype are plotted as the means SE. *P < 0.001 vs. / ; #P < 0.001 vs. s/s by Students unpaired t test.

FIG. 6. Hypothyroidism in mice with defective LRb-STAT3 signaling. Free T4 was measured by radioimmunoassay in serum from terminal bleeds of 8-week-old mice of the indicated genotypes. Data are plotted as the means SE for n > 9 animals of each genotype. *P < 0.01 vs. / by Students unpaired t test.

gest that while nonshivering thermogenesis mediated by BAT UCP1 may be similarly impaired in s/s and db/db animals, the increased lean mass of s/s animals may enable compensatory increases in shivering thermogenesis in s/s compared with db/db animals during acute cold exposure (as in Fig. 4), although it is also possible that differences in the ability to control cold loss through vasoconstriction could play a role. Furthermore, because BAT UCP1 expression primarily reects SNS activity (20 22), these data suggest similarly impaired SNS tone in s/s and db/db animals. Thyroid hormone represents a major leptin-regulated endocrine mediator of metabolic rate; alterations in thyroid function often result in changes in body weight

FIG. 5. Effect of leptin receptor mutations on BAT UCP1 expression. The 8-week-old male mice of the indicated genotypes were killed, and then intrascapular BAT was collected and frozen. Equivalent amounts of protein from BAT lysates were resolved on a single SDS-PAGE gel, transferred to nitrocellulose, and immunoblotted for UCP1 protein. Detection of immunoreactive UCP1 was by 125I-protein A, and quantication was performed on a phosphorimager. Data are plotted as the means of arbitrary phosphorimager units (AU) of immunoreactivity per milligram of protein SE, where the mean reactivity of / mice is normalized to 100. *P < 0.001 vs. / by Students unpaired t test. DIABETES, VOL. 53, DECEMBER 2004

caused by dysregulation of metabolic rate and thermogenesis. To assess the role of LRb3 STAT3 signaling in the control of thyroid function, free thyroxine (T4) levels were measured in 8-week-old s/s mice. Compared with / mice, s/s animals displayed a 31 7% decrease in serum free T4 concentrations (Fig. 6), which was similar to the 39 9% decrease observed in db/db mice compared with / animals. These data are consistent with the hypothesis that leptin mediates control of the thyroid axis via the LRb3 STAT3 pathway, and they suggest that differences in energy expenditure between s/s and db/db animals are not attributable to differences in thyroid function. Although we were unable to examine levels of active (T3) thyroid hormone in these animals, the nding of decreased T4 is consistent with the previous description by others of hypothyroidism in rodents and humans that are decient in leptin (9,3336). In aggregate, the data presented here are consistent with modest changes in energy balance in s/s compared with db/db mice that are attributable to increased lean body mass, whereas the neuroendocrine regulation of metabolic rate is similarly impaired in s/s and db/db animals, suggesting that leptin signals mediated via the LRb-STAT3 pathway are crucial for leptin regulation of energy expenditure in addition to leptin regulation of appetite. The obesity of s/s mice is caused not only by hyperphagia but also by disrupted neuroendocrine regulation of energy expenditure. Investigation of ambulatory activity in s/s mice revealed that although movement is dramatically reduced in these animals compared with wild-type mice, it is slightly increased in s/s compared with db/db mice. Although the mechanism by which lack of leptin signaling decreases activity is not clear, possibilities include lack of motivation or the presence of physical impediments. We speculate that the physical impediments to movement may be slightly reduced in s/s compared with db/db mice because s/s animals have greater lean mass and distribute their adipose mass over a greater body length than db/db mice (29). Certainly, this modest increase in activity in s/s compared with db/db animals did not signicantly alter overall energy expenditure because neither the total nor the
3071

REGULATION OF ENERGY EXPENDITURE BY LEPTIN

resting metabolic rate of s/s mice, as assessed by VO2, were different from those observed in db/db animals; the nding of similar respiratory quotient for each genotype suggests that these VO2 measurements reect relative energy expenditure with reasonable accuracy. Because the activity levels of s/s and db/db animals are dramatically reduced compared with / animals, the modest differences in activity between s/s and db/db animals are likely overwhelmed by the dramatic alterations in basal metabolic rate. The trend toward increased feeding in db/db compared with s/s animals, though not statistically signicant (29), may also result in increased feeding thermogenesis in db/db animals that could counter the effect of the modestly increased activity of s/s mice on 24-h O2 consumption. The nding that resting metabolic rate is similarly decreased in both s/s and db/db mouse models suggests that although signals independent of STAT3 may contribute to activity (and possibly also to shivering thermogenesis), the LRbSTAT3 signal is required for the majority of the neuroendocrine regulation of the metabolic rate. By extension of our previous ndings of impaired hypothalamic melanocortin action with preserved neuropeptide Y (NPY) repression in s/s mice (29), our present results also suggest the importance of melanocortin action in the regulation of energy expenditure by leptin. Whereas the ability to maintain body temperature in response to acute cold exposure is impaired in s/s compared with control mice, it is also improved compared with db/db animals. This intermediate acute cold tolerance phenotype of s/s animals is consistent with decreased neuroendocrine-regulated energy expenditure coupled with improved shivering thermogenesis compared with db/db animals. The hypothesis of increased shivering thermogenesis in s/s compared with db/db mice is commensurate with the increased muscle mass of s/s animals and their ability to support increased activity compared with db/db mice. The inability of ob/ob and db/db mice to tolerate cold exposure is caused in part by decreased BAT UCP1 expression (20 22,37). The nding of equivalently decreased BAT UCP1 expression in s/s and db/db animals is consistent with the impaired cold tolerance of s/s animals and suggests that the LRb-STAT3 signal is critical to the regulation of UCP1 expression, and, by extension, of SNS tone. Although the mechanisms by which leptin regulates sympathetic tone and BAT UCP1 expression are not entirely clear, a great deal of evidence favors a primary role of melanocortin action. For example, mice null for the melanocortin receptor MC4R are resistant to leptin-induced UCP1 expression (38). Similarly, leptin-induced UCP1 expression can be blocked by melanocortin antagonists (18), and the melanocortin agonist melanotan II increases BAT UCP1 expression. These ndings are consistent with the impairment of hypothalamic melanocortin action in s/s animals (29). Other evidence suggests a role for signaling by phosphatidylinositol 3 -kinase in hypothalamic melanocortin action, leptin-regulated SNS activity, and BAT UCP1 expression (13). These data and our ndings are not mutually exclusive because it is possible that STAT3 and phosphatidylinositol 3 -kinase are each critical for the regulation of these events by leptin. One of the primary indicators that leptin regulates the
3072

hypothalamic-pituitary-thyroid axis was the nding that db/db and ob/ob mice have signicantly decreased serum free thyroxin levels, because it has been demonstrated that leptin depletion in mice caused by chronic fasting results in a fall in thyroid hormones that can be blunted if leptin is administered during starvation (9,14). Pro-TRH is highly expressed in the parvocellular region of the paraventricular nuclei of the hypothalamus; during starvation, pro-TRH expression in the paraventricular nuclei is suppressed, depressing thyroid-stimulating hormone secretion from the anterior pituitary and resulting in a fall in circulating levels of the thyroid hormones T3 and T4 (39). A number of mechanisms have been proposed to account for the leptin-mediated regulation of pro-TRH mRNA in the hypothalamus and thus regulation of circulating thyroid hormone levels. Indeed, several authors have suggested that LRb-STAT3 signaling may directly activate pro-TRH expression in pro-TRH expressing hypothalamic neurons (16,17); this mechanism is consistent with our nding of depressed thyroid function in s/s animals. Leptin may also regulate pro-TRH indirectly via projections from LRbexpressing proopiomelanocortin and/or NPY-expressing neurons from the hypothalamic arcuate nucleus (40 42). However, the nding that s/s mice do not possess elevated hypothalamic NPY mRNA (unlike db/db mice) (29), but do display similar repression of the thyroid axis compared with db/db mice, suggests that leptin control of TRH message is predominantly mediated via direct LRb-STAT3 signaling in the TRH neuron or via projections from proopiomelanocortin/neurons, as opposed to via NPY neurons. In the absence of leptin signaling, as in ob/ob or db/db mice, the reproductive, growth, and thyroid axes are inhibited, along with the SNS (9). In contrast, whereas s/s mice display intact reproductive and growth function (29), overall energy expenditure (with the exception of that attributable to increased lean mass) is similar to that of db/db animals, as is the repression of thyroid function and the SNS. Thus, the LRb-STAT3 pathway not only controls the majority of chronic feeding behavior but is also the primary determinant of overall energy expenditure. Thus, although it is possible that STAT3-independent LRb signals may also be important in mediating these and other leptin actions, the LRb-STAT3 signal represents a reasonable candidate as a site of intracellular leptin resistance in obesity.
ACKNOWLEDGMENTS

This work was supported by National Institutes of Health Grants DK56731 and DK57768 (to M.G.M.), grants from the American Diabetes Association (to M.G.M.), National Institutes of Health Grant DK53978 (to E.M.-F.), and an American Diabetes Association/European Association for the Study of Diabetes transatlantic fellowship (to S.H.B.). We thank Francis Marino for assistance.
REFERENCES
1. Green SM: Obesity: prevalence, causes, health risks and treatment. Br J Nurs 6:11811185, 1997 2. Hubert HB, Feinleib M, McNamara PM, Castelli WP: Obesity as an independent risk factor for cardiovascular disease: a 26 year follow-up of participants in the Framingham Heart Study. Circulation 67:968 977, 1983 3. Leibel RL, Chung WK, Chua SC Jr: The molecular genetics of rodent single gene obesities. J Biol Chem 272:3193731940, 1997 4. Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 395:763770, 1998 DIABETES, VOL. 53, DECEMBER 2004

S.H. BATES AND ASSOCIATES

5. Elmquist JK, Maratos-Flier E, Saper CB, Flier JS: Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci 1:445 449, 1998 6. Elmquist JK, Elias CF, Saper CB: From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22:221232, 1999 7. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425 432, 1994 8. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543546, 1995 9. Ahima RS, Prabakaran D, Mantzoros CS, Qu D, Lowell BB, Maratos-Flier E, Flier JS: Role of leptin in the neuroendocrine response to fasting. Nature 382:250 252, 1996 10. Ahima RS, Dushay J, Flier SN, Prabakaran D, Flier JS: Leptin accelerates the onset of puberty in normal female mice. J Clin Invest 99:391395, 1997 11. Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS: Leptin inhibition of the hypothlamic-pituitary-adrenal axis in response to stress. Endocrinology 138:3859 3863, 1997 12. Yu WH, Kimura M, Walczewska A, Karanth S, McCann SM: Role of leptin in hypothalamic-pituitary function. Proc Natl Acad Sci U S A 94:10231028, 1997 13. Rahmouni K, Haynes WG, Morgan DA, Mark AL: Intracellular mechanisms involved in leptin regulation of sympathetic outow. Hypertension 41:763 767, 2003 14. Ahima RS, Saper CB, Flier JS, Elmquist JK: Leptin regulation of neuroendocrine systems. Front Neuroendocrinol 21:263307, 2000 15. Hisano S, Fukui Y, Chikamori-Aoyama M, Aizawa T, Shibasaki T: Reciprocal synaptic relations between CRF-immunoreactive- and TRH-immunoreactive neurons in the paraventricular nucleus of the rat hypothalamus. Brain Res 620:343346, 1993 16. Huo L, Munzberg H, Nillni EA, Bjorbaek C: Role of signal transducer and activator of transcription 3 in regulation of hypothalamic trh gene expression by leptin. Endocrinology 145:2516 2523, 2004 17. Guo F, Bakal K, Minokoshi Y, Hollenberg AN: Leptin signaling targets the thyrotropin-releasing hormone gene promoter in vivo. Endocrinology 145:22212227, 2004 18. Satoh N, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Nakao K: Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett 249:107110, 1998 19. Lowell BB, S-Susulic V, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP, Flier JS: Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366:740 742, 1993 20. Cannon B, Nedergaard J: Brown adipose tissue: function and physiological signicance. Physiol Rev 84:277359, 2004 21. Kozak LP, Koza RA: Mitochondria uncoupling proteins and obesity: molecular and genetic aspects of UCP1. Int J Obes Relat Metab Disord 23 (Suppl. 6):S33S37, 1999 22. Lowell BB, Bachman ES: Beta-adrenergic receptors, diet-induced thermogenesis, and obesity. J Biol Chem 278:2938529388, 2003 23. Flier JS, Lowell BB: Obesity research springs a proton leak. Nat Genet 15:223226, 1997 24. Ihle JN, Kerr IM: Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet 11:69 74, 1995 25. Taniguchi T: Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251255, 1995 26. Kloek C, Haq AK, Dunn SL, Lavery HJ, Banks AS, Myers MG Jr: Regulation of Jak kinases by intracellular leptin receptor sequences. J Biol Chem 277:41547 41555, 2002

27. Bjorbaek C, Buchholz RM, Davis SM, Bates SH, Pierroz DD, Gu H, Neel BG, Myers MG Jr, Flier JS: Divergent roles of SHP-2 in ERK activation by leptin receptors. J Biol Chem 276:4747 4755, 2001 28. Banks AS, Davis SM, Bates SH, Myers MG Jr: Activation of downstream signals by the long form of the leptin receptor. J Biol Chem 275:14563 14572, 2000 29. Bates SH, Stearns WH, Schubert M, Tso AWK, Wang Y, Banks AS, Dundon TA, Lavery HJ, Haq AK, Maratos-Flier E, Neel BG, Schwartz MW, Myers MG Jr: STAT3 signaling is required for leptin regulation of energy balance but not reproduction. Nature 421:856 859, 2003 30. Chua SC Jr, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia LA, Leibel RL: Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271:994 996, 1996 31. Chua SC Jr, Koutras IK, Han L, Liu SM, Kay J, Young SJ, Chung WK, Leibel RL: Fine structure of the murine leptin receptor gene: splice site suppression is required to form two alternatively spliced transcripts. Genomics 45:264 270, 1997 32. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP: Evidence that the diabetes gene encodes the leptin receptor: identication of a mutation in the leptin receptor gene in db/db mice. Cell 84:491 495, 1996 33. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S, Lechler RI, Depaoli AM, ORahilly S: Benecial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deciency. J Clin Invest 110:10931103, 2002 34. Rosenbaum M, Murphy EM, Heymseld SB, Matthews DE, Leibel RL: Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab 87:23912394, 2002 35. Chan JL, Heist K, Depaoli AM, Veldhuis JD, Mantzoros CS: The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest 111:1409 1421, 2003 36. Oral EA, Ruiz E, Andewelt A, Sebring N, Wagner AJ, Depaoli AM, Gorden P: Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy. J Clin Endocrinol Metab 87:3110 3117, 2002 37. Scarpace PJ, Matheny M: Leptin induction of UCP1 gene expression is dependent on sympathetic innervation. Am J Physiol 275:E259 E264, 1998 38. Ste ML, Miura GI, Marsh DJ, Yagaloff K, Palmiter RD: A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl Acad Sci U S A 97:12339 12344, 2000 39. Bates SH, Myers MG: The role of leptin3 STAT3 signaling in neuroendocrine function: an integrative perspective. J Mol Med 82:1220, 2004 40. Legradi G, Lechan RM: The arcuate nucleus is the major source for neuropeptide Y-innervation of thyrotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Endocrinology 139:32623270, 1998 41. Fekete C, Legradi G, Mihaly E, Huang QH, Tatro JB, Rand WM, Emerson CH, Lechan RM: Alpha-melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fastinginduced suppression of prothyrotropin-releasing hormone gene expression. J Neurosci 20:1550 1558, 2000 42. Mihaly E, Fekete C, Tatro JB, Liposits Z, Stopa EG, Lechan RM: Hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the human hypothalamus are innervated by neuropeptide Y, agouti-related protein, and alpha-melanocyte-stimulating hormone. J Clin Endocrinol Metab 85:2596 2603, 2000

DIABETES, VOL. 53, DECEMBER 2004

3073